Carbon Dots for Diagnostic Analysis and Drug Delivery (EP3411330A1)

The EPO granted patent EP3411330A1 covering carbon dot compositions for diagnostic analysis and drug delivery applications. The patent names inventors Li Shanghao, Leblanc Roger M., Skromne Isaac, and Peng Zhili from the University of Miami. Designated contracting states include most EU member states and additional European countries.

For pharmaceutical and biotechnology companies developing carbon-based nanomedicines or diagnostic technologies, this patent may affect freedom-to-operate considerations. Research institutions and manufacturers should assess whether their technologies fall within the scope of the claimed carbon dot compositions and therapeutic applications including diabetes, bone disorders, and neurological conditions.